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Arrhythmia mutations in calmodulin can disrupt cooperativity of Ca2+ binding and cause misfolding 
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Key points 
 Mutations in the calmodulin protein (CaM) are associated with arrhythmia 
syndromes. 
 This study focuses on understanding the structural characteristics of CaM disease 
mutants and their interactions with the calcium channel. 
 Arrhythmia mutations in CaM can lead to loss of Ca2+ binding, uncoupling of Ca2+ 
binding cooperativity, misfolding of the EF-hands, and altered affinity for the calcium 
channel. 
 These results help us to understand how different CaM mutants have distinct effects 









Calmodulinopathies are life-threatening arrhythmia syndromes that arise from mutations in 
calmodulin (CaM), a calcium sensing protein whose sequence is completely conserved across 
all vertebrates. These mutations have been shown to interfere with the function of cardiac ion 
channels, including the voltage-gated Ca
2+
 channel CaV1.2 and the Ryanodine Receptor 
(RyR2), in a mutation-specific manner. The ability of different CaM disease mutations to 
discriminate between these channels has been enigmatic. We present crystal structures of 
several C-terminal lobe mutants and an N-terminal lobe mutant in complex with the CaV1.2 
IQ domain, in conjunction with binding assays and complementary structural biology 
techniques. One mutation (D130G) causes a pathological conformation, with complete 
separation of EF-hands within the C-lobe and loss of Ca
2+
 binding in EF-hand 4. Another 
variant (Q136P) has severely reduced affinity for the IQ domain, and shows changes in the 
CD spectra under Ca
2+
-saturating conditions when unbound to IQ domain. Ca
2+
 binding to a 
pair of EF-hands normally proceeds with very high cooperativity, but we find that N98S CaM 
can adopt different conformations with either one or two Ca
2+
 ions bound to the C-lobe, 
possibly disrupting the cooperativity. An N-lobe variant (N54I), which causes severe stress-
induced arrhythmia, does not show any major changes in complex with the IQ domain, 
providing a structural basis for why this mutant does not affect function of CaV1.2. These 
findings show that different CaM mutants have distinct effects on both the CaM structure and 
















Calmodulin (CaM) is a ubiquitously expressed Ca
2+
 sensor and signal transducer that 
modulates many cellular processes(Friedberg & Rhoads, 2001). It consists of four classical 
Ca
2+
-binding EF-hands (EF1-4) located in two globular N-terminal (N-lobe) and C-terminal 
(C-lobe) domains. Ca
2+
 binding to the EF-hands within each lobe is highly 
cooperative(Beccia et al., 2015), and the different Ca
2+
 affinities between the lobes allow 
CaM to mediate signaling over a range of cytosolic Ca
2+
 concentrations through interactions 
with numerous targets, including the L-type voltage-gated Ca
2+
 channel (CaV1.2)(Ben-Johny 
& Yue, 2014) and cardiac ryanodine receptor (RyR2)(Van Petegem, 2012; Gong et al., 
2019). Upon Ca
2+
 binding, concerted movements of helices in the EF-hands from an 
antiparallel to orthogonal position allow CaM to undergo a “closed-to-open” structural 
transition, exposing hydrophobic patches that allow for target recognition. CaV1.2, the main 
voltage-gated Ca
2+
 channel isoform expressed in the heart, is known to undergo a Ca
2+
-
dependent feedback process, known as Ca
2+
-dependent inactivation (CDI). Binding of CaM 
to an IQ motif in the C-terminal tail of CaV1.2 is essential for CDI, and replacement of the 
consensus isoleucine 1624 residue with alanine was shown to abolish CDI(Peterson et al., 
1999; Zuhlke et al., 1999). Additionally, overexpression of Ca
2+
-insensitive CaM drastically 
prolongs the ventricular action potential in guinea pig ventricular myocytes, giving the first 
hint that CaM mutations may give a predisposition to ventricular arrhythmias(Alseikhan et 
al., 2002). 
Three human genes (CALM1, CALM2, and CALM3) located on different chromosomes 
encode for the same CaM protein, and this protein sequence is entirely conserved across 
vertebrates(Fischer et al., 1988). Despite this redundancy, mutation in only one of the six 
CaM alleles has been associated with life-threatening cardiac disorders such as long QT 
syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). The 
first arrhythmogenic CaM mutation was identified in a large Swedish family with severe, 
dominantly-inherited CPVT, presenting with ventricular arrhythmias, syncope, and sudden 
cardiac death(Nyegaard et al., 2012). Genome-wide linkage analysis revealed a substitution 
of asparagine for isoleucine at position 54 of CaM, prompting genetic screening for mutations 
in CALM genes in individuals with CPVT. A de novo asparagine to serine substitution at 
position 98 was subsequently found in a patient with early-onset CPVT. To date, N98S CaM 
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variant(Crotti et al., 2019; Fujita et al., 2019). It is also the mutation with the most 
phenotypic variability, manifesting as LQTS, CPVT, idiopathic ventricular fibrillation (IVF), 
or mixed symptoms in different individuals. Another hotspot for CaM variation is position 
130, with substitution of aspartate for glycine found in six families(Crotti et al., 2013; Crotti 
et al., 2019; Wren et al., 2019). D130G CaM gives rise to a strictly LQTS phenotype, in 
accordance with the observation that most variants in EF4 are associated with LQTS. The 
Q136P EF4 mutation is one of the few exceptions, identified in a patient diagnosed with 
mixed LQTS and CPVT symptoms(Makita et al., 2014). The different cardiac phenotypes of 
different CaM mutations, and even diverse phenotypes of the same mutation, raise questions 
about the disease mechanism. In particular, the ability of some mutants to associate only with 
CPVT and not long-QT, or vice versa, has been enigmatic. The N54I mutant, for example, 
affects the function of RyR2, but spares the CDI of CaV1.2, but the structural reason for this 
is unknown. 
Here, we structurally characterize four CaM variants by high-resolution X-ray 
crystallography: an N-lobe mutation (N54I), an EF3 mutation (N98S), and two EF4 
mutations (D130G and Q136P). Together with binding assays and NMR data, we shed light 
on the distinct mechanisms of each CaM disease mutant. 
METHODS 
Cloning, expression, and purification. The IQ domain of human CaV1.2 (CaVα1c77) 
(residues 1611-1641) were cloned as previously described(Van Petegem et al., 2005) into a 
modified pET28 vector containing, in tandem, an N-terminal hexahistidine tag, maltose-
binding protein (MBP), and cleavage site for the tobacco etch virus (TEV) protease. Full-
length human CaM was cloned into pEGST which lacks any affinity tag. The N54I, N98S, 
D130G, and Q136P mutations were produced by the QuikChange protocol (Stratagene). Co-
expression and co-purification procedures for the CaM:IQ domain complexes were 
described(Wang et al., 2018). 
 Samples of WT and D130G Ca
2+
/CaM:IQ complexes were passed through a Superdex 
75 10/300 GL (GE Healthcare) gel filtration column for analytical size determination. The 
protein buffer was exchanged to 25 mM NaCl, 10 mM HEPES, pH 7.4, and 10 mM CaCl2 
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TAMRA fluorescence anisotropy experiments. Buffered solutions, experimental methods, 
and curve fitting were as previously described(Wang et al., 2018). Differences in the CaV1.2-
IQ peptide affinity between CaM mutants and wild-type were evaluated by a one-way 
ANOVA at each Ca
2+
-concentration with Dunnett’s multiple comparisons test. 
Crystallization, data collection, and structure solution. Crystals were obtained by 
hanging-drop vapour diffusion by mixing equal volumes of protein (~25 mg.ml
-1
) and 
reservoir solution. Complexes of N54I Ca
2+
/CaM:IQ domain were crystallized in a solution 
of 23.6% PEG 3350 (w/v) and 0.1 M citric acid, pH 4, at 25 
o
C. Crystals of the N98S 
Ca
2+
/CaM:IQ domain complex appeared in a solution of 2.1 M DL-malic acid, pH 7.46, at 4 
o
C. DL-malic acid chelates Ca
2+
 ions; the free Ca
2+
 concentration after mixing the protein 
buffer (containing 10 mM CaCl2) and reservoir solution was ~10 μM, as measured by an ion-




). The D130G 
Ca
2+
/CaM:IQ domain complex crystallized in a solution of 1.86 M ammonium sulfate at 25 
o
C. The Q136P Ca
2+
/CaM:IQ domain complex appeared in a solution of 15.8% PEG 550 
MME (v/v) and 0.1 M sodium acetate, pH 4, at 25 
o
C. 
After flash-freezing in liquid nitrogen, diffraction data were collected at the Stanford 
Synchrotron Radiation Lightsource beamline 9-2 (N98S and Q136P Ca
2+
/CaM:IQ 
complexes) and the Advanced Photon Source beamline 23ID-D (N54I and D130G 
Ca
2+
/CaM:IQ complexes) and processed using XDS(Kabsch, 2010). 
The structures were solved by molecular replacement using Phenix(Adams et al., 
2010) and using, as search models, F142L Ca
2+





/CaM (PDB ID: 2BE6) for N98S Ca
2+
/CaM:IQ, and wild-type 
Ca
2+
/CaM (PDB ID: 3G43) for D130G Ca
2+
/CaM:IQ. The structures were refined using 
COOT(Emsley & Cowtan, 2004) and Phenix(Adams et al., 2010). No residues are in 
disallowed regions of the Ramachandran plot. Final models contain one (Q136P 
Ca
2+
/CaM:IQ), two (N54I and N98S Ca
2+
/CaM:IQ), or ten (D130G Ca
2+
/CaM:IQ) complexes 
in the asymmetric unit. A Na
+
 ion was placed in EF3 of N98S Ca
2+
/CaM (chain A); the 






, or a 
water molecule(Zheng et al., 2017). Molecular graphics were prepared using PyMOL 
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Table 1. Coordinates have been deposited in the Protein Data Bank with accession codes 
6U39, 6U3A, 6U3B, and 6U3D. 
Circular dichroism. Circular dichroism spectra were recorded using a Chirascan-Plus 
circular dichroism spectrometer for 20 µM CaM in buffer (4 mM HEPES, 20 mM KCl, pH 
7.2) with either 1 mM CaCl2 or EDTA added. The spectra were converted to mean residue 
ellipticity (ϴMRE) after buffer subtraction. Secondary structure elements were calculated using 
the CDSSTR algorithm(Sreerama & Woody, 2000) with protein reference set 4 on the 
DichroWeb platform(Whitmore & Wallace, 2004). The algorithm predicts secondary 
structure elements based on 6 classifications: regular and distorted ɑ-helix, regular and 
distorted ß-sheet, turns, and unordered. Statistically significant differences (P < 0.05) in 
structural elements between CaM variants were evaluated by a two-way ANOVA with a 
Holm-Sidak post hoc test. 
NMR experiments. 
15
N-labelled WT/D96V/N98S CaM was expressed and purified as 
previously described(Wang et al., 2018). 200 µM of Ca
2+
-bound WT/D96V/N98S CaM was 
saturated with a synthetic peptide (>97% purity, Proteogenix, France) corresponding to the 
IQ domain of human CaV1.2 (DEVTVGKFYATFLIQEYFRKFKKRKEQGLVGKPS-NH2). 
The sample was then centrifuged for 1 min at 12,300 x g and the supernatant was loaded onto 
a Superdex 75 HiLoad 16/60 gel filtration column equilibrated with 2 mM HEPES, 10 mM 
KCl, 1 mM CaCl2, pH 6.7. The eluate was concentrated to 500 µL in a 3 kDa MWCO filter. 
All NMR samples contained: 200 µM Ca
2+
CaM:IQ complex, 2 mM HEPES, 10 mM KCl, 1 
mM CaCl2, 2 mM NaN3, 0.1 mM TSP-d4 (sodium 2,2,3,3-tetradeutero, 3-(trimethylsilyl) 
propionate) dissolved in 95 % H2O, 5 % D2O. WT and N98S samples had pH 6.58, while the 




N-HSQC NMR spectra were recorded on a BRUKER AVIII-600 MHz 
spectrometer equipped with a CPP-TCI probe. Spectra were acquired at 298.1 K. BRUKER 
TopSpin 3.5pl6 was used for recording and processing. 
RESULTS 
In this manuscript, we use the numbering based on the open reading frame of CaM, with the 
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Calmodulin mutants have different effects on binding to the CaV1.2 IQ domain 
We investigated several CaM disease mutants previously associated with only CPVT, only 
LQTS, or mixed LQTS/CPVT phenotypes. To investigate whether they have aberrant 
interactions with the CaV1.2 IQ domain, we used fluorescence anisotropy (FA) to measure 
binding affinity of full-length CaM for the IQ domain over a range of Ca
2+
 concentrations 
(data represent mean ± standard deviation of 3 replicates) (Fig. 1). 
N54I CaM binds the IQ domain with affinities comparable to wild-type (WT) CaM at all 
tested Ca
2+
 concentrations. Because the C-lobe is responsible for high-affinity tethering of 
CaM to the CaV1.2 IQ domain, it is unsurprising that a mutation in the N-lobe has little effect 
on the affinity of full-length CaM for the IQ domain(Fallon et al., 2005; Van Petegem et al., 
2005). Additionally, this mutation was previously shown to have no effect on CaV1.2 
CDI(Limpitikul et al., 2014; Yin et al., 2014). As described before(Wang et al., 2018), N98S 
CaM displays a modest but statistically significant reduction in affinity for the IQ domain in 
the range of 100 nM - 10 μM Ca
2+
. The largest effect is seen for D130G and Q136P CaM, 
which have decreased affinities at all Ca
2+
 concentrations; in particular, the mutants have 10- 
to 1000-fold weaker affinity for the IQ domain at 100 nM - 10 μM Ca
2+
, with the Q136P 
mutation having the most severe impairment in binding. Compared to EF3 CaM mutations, it 
appears that mutations in EF4 are more detrimental to CaM binding to the CaV1.2 IQ 
domain(Wang et al., 2018).  
Previously, the N54I and N98S CaM were analyzed via circular dichroism (CD), showing 
only very subtle differences from WT CaM (1-2%)(Sondergaard et al., 2015a). Here we 
analyzed the Q136P and D130G mutants via CD (data represent mean ± standard deviation of 
4 replicates) (Fig 1B-D). Both of these showed significant differences in Ca
2+
-saturated 
conditions, but not under Ca
2+
-free conditions. These two mutants thus have the largest 
effects on both binding to the IQ domain, and Ca
2+
-saturated structure. To gain more insights 
into these mutations, we proceeded with solving crystal structures. 
Crystal structure of the D130G Ca
2+
/CaM:IQ complex 
Asp130 coordinates a Ca
2+
 ion in EF4. The D130G CaM mutation has been associated with 
LQTS(Crotti et al., 2013; Reed et al., 2015; Boczek et al., 2016) and appears to be a CaM 









 concentrations, we sought to structurally characterize the D130G Ca
2+
/CaM:IQ 
domain interaction and solved a 2.4Å crystal structure of the complex in 10mM CaCl2. 
There are ten complexes in the asymmetric unit (AU), and despite the high Ca
2+
 
concentration (mM) used during crystallization, the Ca
2+
-coordinating pocket of EF4 is 
completely disrupted with large changes in main chain positions and loss of Ca
2+
 binding 
(Fig. 2A-C, Supp video 1). The absence of Ca
2+
 has numerous consequences. Electron 
density for many of the Ca
2+
-coordinating side chains in EF4 is absent due to increased 
flexibilities. Asp132 and Asp134, whose side chains protrude into the binding pocket to 
coordinate Ca
2+
 in the wild-type structure, rotate and project outwards from the pocket in the 
mutant. Glu141 also relaxes to a different position, shifting away from the loop by ~3 Å. 
Glycine has more conformational flexibility than other residues and has the largest allowable 
area in the Ramachandran plot. Due to this increased flexibility, the D130G EF4 relaxes to a 
wider conformation than in WT Ca
2+
/CaM. Widths of the EF4 loop between different D130G 
Ca
2+
/CaM chains are also variable when comparing different complexes in the asymmetric 
unit; for example, EF4 of chain K is wider than chain M, which is narrower and more 
elongated. The D130G EF4 conformation is also different from that of WT apoCaM, which 
retains a tight loop structure despite the lack of bound ions (Fig. 2D). Thus, the conformation 
of EF4 in D130G resembles neither a WT Ca
2+
/CaM nor WT apoCaM EF-hand and adopts 
an intrinsic flexibility. 
This local change in EF4 has dramatic consequences on the overall conformation, resulting in 
an unwinding of the D130G C-lobe, with EF-hands 3 and 4 physically uncoupled (Fig. 2E). 
Helices E and F align reasonably to wild-type, but the loop between helices F-G in wild-type 
becomes α-helical in the D130G mutant, such that helices F-G form a single, continuous α 
helix. In the crystal structure, this helix is involved in packing interactions with a neighboring 
D130G CaM:IQ complex, giving rise to an apparent dimer (Fig. 3A-B). In fact, all ten 
complexes in the AU assemble into five of such dimers, suggesting it is relatively stable. 
However, size exclusion chromatography shows that the wild-type and D130G Ca
2+
/CaM:IQ 
complexes elute at volumes corresponding to a single complex (Fig. 3C), and the 
dimerization may thus only arise at high concentrations as found within crystals.  
As a result of the C-lobe misfolding, interactions with the IQ domain residues are different. 
In WT Ca
2+
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globular structure(Fallon et al., 2005; Van Petegem et al., 2005) (Fig. 4A). There are binding 
grooves in the N-lobe for the IQ domain aromatic anchors Phe1618, Tyr1619, and Phe1622, 
and the C-lobe forms hydrophobic pockets for the IQ domain anchoring residues Ile1624, 
Tyr1627, and Phe1628. The D130G N-lobe displays small rearrangements around the IQ 
domain compared to wild-type (Fig. 4B). However, there is inherent variability in the 
positioning of the N-lobe as the WT N-lobe is able to adopt a number of different orientations 
around the IQ domain(Van Petegem et al., 2005), so this change is likely not significant. Due 
to the misfolding of the D130G C-lobe, the contacts between this lobe and the IQ domain are 
completely different, as helices G and H no longer embrace the IQ domain (Fig. 4C-D). 
Ile1624 represents the “I” in IQ domain and is critical for CDI(Peterson et al., 1999; Zuhlke 
et al., 1999). In WT CaM, Ile1624 is bound in a hydrophobic pocket of the C-lobe. In the 
D130G mutant, however, C-lobe residues form few contacts with Ile1624. Tyr1627, the 
primary C-terminal aromatic anchor which is buried in a methionine-rich pocket in WT CaM, 
is largely solvent-exposed in the mutant complex, along with the second major anchoring 
residue Phe1628. This is functionally significant because the WT C-lobe acts as an anchor to 
tether CaM to the IQ domain and the WT N-lobe is labile and can adopt a variety of 
positions(Van Petegem et al., 2005). However, in the D130G mutant, the N-lobe forms the 
majority of contacts with the IQ domain while the C-lobe offers few interactions. 
The D130G mutation thus has several effects on CaM and its interactions with the CaV1.2 IQ 
domain: loss of Ca
2+
 binding in EF4, misfolding of the C-lobe that physically uncouples EF3 
and EF4, and disrupted interactions with the IQ domain. All of these factors may contribute 
to loss of CaV1.2 CDI and the accompanying LQTS phenotype observed in disease. 
Crystal structure of the Q136P Ca
2+
/CaM:IQ complex 
Gln136 is also located in the Ca
2+
-coordinating loop of EF4, although the glutamine side 
chain does not directly participate in Ca
2+
 binding. The Q136P mutation was identified in a 
girl who exhibited both LQTS and CPVT phenotypes(Makita et al., 2014). Given the severe 
perturbations in binding affinity for the IQ domain, we wondered whether this CaM mutation 
also results in large conformational distortions like the D130G mutation. We solved a 1.7Å 
crystal structure of Q136P Ca
2+
/CaM:IQ domain complex, obtained with 10mM CaCl2. This 
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Despite the strict Ramachandran constraints imposed by mutation to proline, Q136P CaM is 
still able to bind Ca
2+
 in EF4, at least under saturating Ca
2+
 conditions. Coordination 
distances between the Ca
2+
 ion and residues in the EF4 loop are comparable to WT CaM 
(2.3-2.6 Å) (Fig. 5A, Supp video 2). The carbonyl oxygen between Gly135 and Pro136 has 
shifted by 1.9 Å (Fig. 5B), resulting in a less favourable backbone conformation which may 
result in a lowered Ca
2+
 affinity, as suggested before for this mutant(Makita et al., 2014). 
Tyr100, located in the EF3 loop, has reoriented, making packing interactions with Pro136 
(Fig. 5C). This position is not possible in WT as it would clash with Gln136. As a result, 
there is a shift in the position of the EF3 loop residues relative to the EF4 loop. In addition, 
changes in the C-lobe alter interactions with the bound IQ domain (Fig. 5D,E). There are 
small changes in side chain positions of the IQ domain, particularly Tyr1627and Phe1628, as 
well as altered electrostatics of the Q136P C-lobe binding surface.  
Crystal structure of N98S Ca
2+
/CaM in complex with the IQ domain 
N98S CaM has been identified individually in patients presenting with CPVT, LQTS, IVF, 
and SUD phenotypes and is the most prevalent out of all CaM disease mutations(Nyegaard et 
al., 2012; Makita et al., 2014; Crotti et al., 2019). The different phenotypes suggest it can 
affect the function of multiple targets. In WT CaM, Asn98 coordinates a Ca
2+
 ion in EF3 of 
the C-lobe. A previously determined structure of the N98S mutant showed minimal effects on 
structure(Wang et al., 2018), a result that seems at odds with the fact that this mutation can 
slow down CDI significantly, and has lowered affinity for the IQ domain in the concentration 
range of 100 nM – 10 μM free Ca
2+
 (Limpitikul et al., 2014; Wang et al., 2018) (Fig 1). 
However, the previous structure was obtained in the absence of any target peptide. Here we 
were able to solve a structure in complex with the CaV1.2 IQ domain. Fortuitously, the 
crystals were obtained at a free Ca
2+




We solved the corresponding structure at 1.65 Å resolution. There are two complexes in the 
asymmetric unit, and surprisingly, N98S CaM adopts different conformations in these two 
complexes (Supp video 3). In one complex (chains B and D), the N98S Ca
2+
/CaM:IQ 
complex resembles the wild-type structure (Fig. 6). A Ca
2+
 ion is bound in EF3, with 
coordination contributed by both Asn98 and Ser98 side chains (Fig. 6A-B). The N98S C-lobe 




This article is protected by copyright. All rights reserved. 
11 
 
the N98S C-lobe around the IQ domain is similar to wild-type (Fig. 6D). Small changes can 
be seen in the orientation of the N98S N-lobe relative to the IQ domain, but this lobe was 
previously reported to adopt multiple conformations(Van Petegem et al., 2005), and this 
change is unlikely to be a result of the mutation. 
The second N98S Ca
2+
/CaM:IQ complex (chains A and C) in the asymmetric unit does not 
have a Ca
2+
 ion bound in EF3. Glu105, which coordinates the Ca
2+
 in WT CaM, relaxes away 
from the Ca
2+
 binding pocket due to lack of stabilizing Ca
2+
-coordination interactions, 
leading to large-scale allosteric changes and distortions in the C-lobe (Fig. 7A-B). 
Interestingly, a Na
+
 ion is bound in lieu of the Ca
2+
 ion (see Methods). This Na
+
 ion is 
coordinated by the side chains of Asp94, Asp96, Ser98, the carbonyl oxygen of Tyr100, and a 
water molecule. The overall conformation of the C-lobe is reminiscent of the N98I and D96V 
mutants(Wang et al., 2018). In these cases, Ca
2+
 binding to EF3 was abolished, despite the 
presence of saturating (10 mM) Ca
2+
 levels. However, the precise conformation of side 
chains in the EF3 loop is different (Fig. 8A). For example, Tyr100 forms stacking 
interactions with Ile98 and Gln136 in the N98I mutant, but for the N98S mutant Tyr100 takes 
on a position similar to WT. 
Although the conformations of side chains in EF3 are different between the N98S, D96V, and 
N98I mutants, the overall structures of the C-lobes are highly comparable, all of which are 
distinct from the WT Ca
2+
/C-lobe and WT apoC-lobe (Fig. 8B). Additionally, N98S CaM 
displays the same reorientation of N- and C-lobes around the IQ domain that was observed 
for the N98I and D96V mutants, altering its interactions with the IQ domain compared to 
wild-type (Fig. 8C). 
The binding of Ca
2+
 to a pair of EF hands in WT CaM has been found to proceed with a very 
high degree of cooperativity(Minowa & Yagi, 1984; Tsalkova & Privalov, 1985; Wang, 
1985; Linse et al., 1991; Ikura, 1996; Sorensen & Shea, 1998; Masino et al., 2000; VanScyoc 
& Shea, 2001; Beccia et al., 2015), such that it is rare to have a stable version with only one 
Ca
2+
 bound to an individual lobe. However, the N98S mutation may be able to reduce this 
cooperativity, yielding a C-lobe with only a single Ca
2+
 bound at a physiologically relevant 
Ca
2+
 concentration. This is in contrast with our previous analysis of this mutant in the 
absence of the IQ domain, whereby four molecules in the asymmetric unit all retained Ca
2+
 









 in the crystallization condition (μM in this study, mM in the previous study). However, 
as another difference is the presence or absence of an IQ domain, we wished to test the effect 
of the mutant, in the presence of IQ domain, under saturating Ca
2+
 levels. 
Investigation of the N98S Ca
2+
/CaM:IQ complex via NMR spectroscopy 
As we were unable to crystallize the N98S CaM:IQ complex under mM free Ca
2+
 
concentrations, we instead reverted to NMR spectroscopy, and measured HSQC spectra 
under saturating Ca
2+




N]-HSQC spectra of N98S 
and WT Ca
2+
/CaM:IQ complexes shows that the N98S mutant is highly comparable to the 
wild-type population with only minor changes that can be expected as a consequence of a 
single point mutation. The differences between wild-type and N98S CaM are much smaller 
than the differences seen between the wild-type and D96V (Fig. 10). 
These results thus suggest that the difference in conformations for N98S CaM, observed 
previously(Wang et al., 2018) and in this study, are due to the free Ca
2+
 concentrations, and 
not to the presence or absence of the IQ domain.  
Crystal structure of the N54I Ca
2+
/CaM:IQ complex 
While the previous structures have focused on CaM mutations associated with LQTS, the 
most prevalent phenotype for CaM variants, we wished to compare it to the structure of a 
CaM mutant not associated with LQTS. The N54I mutation was initially identified in a large 
Swedish family with severe CPVT and subsequently found in an individual with 
IVF(Nyegaard et al., 2012; Crotti et al., 2019). We crystallized N54I Ca
2+
/CaM in a complex 
with the IQ domain at 10mM CaCl2 and solved the structure at 1.75 Å resolution. 
Unlike many of the C-lobe mutants which affect residues in EF-hand loops, the N54I 
mutation is located in helix C of the N-lobe. The overall structure is similar to WT Ca
2+
/CaM, 
with N54I CaM binding to the IQ domain in a parallel orientation and full Ca
2+
 occupancy in 
all four EF-hands (Fig. 11A). The N54I N-lobe aligns well with WT N-lobe (RMSD 0.361 Å) 
(Fig. 11B). The largest change is immediately adjacent to the mutation site, with a change in 
the side chain conformation of Gln50 (Fig. 11C). However, no changes are detected in 
residues that coordinate Ca
2+
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These results support the lack of any significant effect of the N54I mutation on CDI of 
CaV1.2(Limpitikul et al., 2014; Yin et al., 2014), and because of the CPVT phenotype in 
several patients, suggest that any mechanism of disease is likely to involve RyR2 or other ion 
channels instead(Pancaroglu & Van Petegem, 2018; Saljic et al., 2019). 
DISCUSSION 
Calmodulinopathies include a range of dominantly inherited arrhythmogenic syndromes such 
as LQTS, CPVT, IVF, and atypical/mixed phenotypes(Nyegaard et al., 2012; Crotti et al., 
2013; Marsman et al., 2014; Crotti et al., 2019). These life-threatening disorders are often de 
novo and early-onset and can be caused by mutation in any one of the three CALM genes. In 
the heart, CaM modulates voltage-gated calcium, sodium, and potassium channels, as well as 
RyR2(Van Petegem et al., 2012; Sorensen et al., 2013; Lau et al., 2014; Sun & MacKinnon, 
2017). CaV1.2 contributes towards depolarization, and CaM-mediated CDI of the channel is 
essential for proper repolarization. Several LQTS-associated CaM mutants were found to 
have decreased Ca
2+
 affinity and reduced CDI of CaV1.2, thus resulting in a lengthened action 
potential and QT interval prolongation(Limpitikul et al., 2014; Yin et al., 2014). 
Here we analyze the effect of mutations on the structure of CaM in the presence of the 
CaV1.2 IQ domain. An intrinsic limitation is that we are lacking the upstream EF-hand 
domain, which also plays a role in CDI(Ben Johny et al., 2013). So far any CaV construct 
containing this element has failed to produce properly folded protein, in contrast to the 
progress made for voltage-gated sodium channels(Wang et al., 2012; Gabelli et al., 2014; 
Wang et al., 2014; Gardill et al., 2019; Yoder et al., 2019). Our structural studies of CaM 
disease mutants show that different mutations have distinct effects on the structure in the 
presence of the CaV1.2 IQ domain, despite the fact that most, but not all, have a similar 
functional outcome on CDI: 
1) Permanent loss of Ca
2+
 binding to EF3, resulting in a distorted C-lobe. EF3 and EF4 are 
still in physical contact (D96V and N98I mutants)(Wang et al., 2018). 
2) Decreased affinity of EF3 for Ca
2+
, leading to potential loss of cooperativity of Ca
2+
 
binding to EF3 and EF4. At high mM Ca
2+
 concentrations, both EF3 and EF4 are Ca
2+
 
occupied(Wang et al., 2018). At lower, μM Ca
2+
 concentrations, EF3 can be Ca
2+
 free, and 
EF4 Ca
2+
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3) Abolished binding of Ca
2+
 to EF4 and a structural distortion that physically uncouples EF3 
and EF4 (D130G). 
4) Structural distortions of Ca
2+
/CaM that appear only visible in the absence of an IQ domain. 
The presence of an IQ domain stabilizes the structure (Q136P). 
5) Minimal effect on Ca
2+
/CaM, but structural distortions of the Ca
2+
-free state, which 
increase the affinity for the IQ domain (F142L)(Wang et al., 2018). 
6) No significant effects on the structure, at least in complex with the IQ domain (N54I). 
Of note, all LQTS-associated CaM mutants investigated so far still maintain substantial 
affinity for the IQ domain under low Ca
2+
-conditions, making the mutant versions effective 
competitors for wild-type CaM. As apoCaM pre-association with the IQ domain is essential 
for CDI, this immediately explains the dominant nature of the calmodulinopathies: it implies 
that the fraction of the channels preassociated with a LQTS-mutant CaM will simply not 
undergo CDI due to the perturbations of the Ca
2+
-bound state or alterations in the Ca
2+
 
affinity and cooperativity. The resulting loss of CDI for this fraction of channels is sufficient 
to cause LQTS(Limpitikul et al., 2014). 
The most dramatic effects are observed for the D130G mutant. Due to misfolding of the C-
lobe, the D130G Ca
2+
/C-lobe no longer forms significant contacts with the IQ domain, and it 
is the D130G Ca
2+
/N-lobe that makes the majority of interactions with the IQ domain (Fig. 
4). This is also reflected in the decreased affinity of D130G CaM for the IQ domain, 
compared to wild-type, across all Ca
2+
 concentrations tested (Fig. 1). Helices F-G form a 
continuous α helix in the D130G crystal structure (Fig. 3), and the protein forms a dimer in 
all ten molecules of the AU. The D130G Ca
2+
/CaM:IQ complex was found to be in a 1:1 
complex in solution, so this dimer may not exist in physiological conditions. Because C-lobe 
binding to the CaV1.2 IQ domain is critical for CDI(Peterson et al., 1999; Zuhlke et al., 
1999), the grossly perturbed D130G Ca
2+
/C-lobe:IQ domain interaction would explain the 
strong suppression of CDI(Limpitikul et al., 2014). 
The D130G mutation also disrupts the Ca
2+
-coordination pocket of EF4 and abolishes ion 
binding. Indeed, the D130G mutation has 54-fold lower affinity compared to wild-type(Crotti 
et al., 2013). It is thus possible that similar uncoupling of EF3 and EF4 also occurs in the 
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resolution structure of this mutant in the absence of Ca
2+
, the CD data suggest that there are 
no major distortions in the Ca
2+
-free state (Fig. 1B). Given the severe C-lobe conformational 
distortions (Fig. 2E), changes in surface electrostatics (Fig. 4) and reduced Ca
2+
 affinity, it is 
likely that D130G CaM interactions with other binding targets are also affected, not just that 
with the CaV1.2 IQ domain. Indeed, out of six arrhythmia-causing CaM variants (N54I, 
F90L, D96V, N98S, D130G, and F142L) studied by Berchtold et al., the D130G mutant has 
the most profound effect on viability of a vertebrate cell line, suggesting that D130G CaM, in 
the absence of any WT CaM, is unable to support basic cell functions(Berchtold et al., 2016). 
D130G CaM was shown to increase SR Ca
2+
 release from RyR2 and lowered both the 
activation and termination threshold for store overload-induced Ca
2+
 release 
(SOICR)(Sondergaard et al., 2015b). It was also found to increase the fetal NaV1.5 late 
current in heterologous cells (but not in fetal ventricular myocytes) and to diminish both 
CaMKII activation and CaMKII substrate phosphorylation(Yin et al., 2014; Berchtold et al., 
2016). In addition to direct regulation by CaM, cardiac ion channels are also regulated by 
CaMKII phosphorylation, so the D130G CaM mutation has possible combined effects of 
aberrant direct modulation of targets as well as aberrant indirect regulation via CaMKII. The 
large number of targets affected by D130G CaM aligns with the observation that this mutant 
causes a severe, early-onset disease phenotype with numerous probands diagnosed at 
birth(Boczek et al., 2016). 
Given the severe reduction in affinity for the IQ domain (Fig. 1), it was surprising that the 
Q136P Ca
2+
/CaM:IQ complex displays subtle conformational changes compared to WT 
Ca
2+
/CaM:IQ in the crystal structure (Fig. 5). It is likely that the IQ domain helps to stabilize 
the structure of Q136P Ca
2+
/CaM to more closely resemble the wild-type conformation. The 
Q136P variant, when unbound to the CaV1.2 IQ domain, may adopt a pathological 
conformation that affects interactions with other molecular targets. Because the Q136P 
mutant is also associated with CPVT(Makita et al., 2014), it is likely to result in 
dysregulation of RyR2. Indeed, this mutant was found to decrease both the activation and 
termination threshold for SOICR, increasing the fractional ER Ca
2+
 release(Sondergaard et 
al., 2019). Further biophysical characterization of Q136P CaM on the function of various ion 
channels is necessary to understand its range of disease pathology. 
A well-known feature of CaM is high cooperativity of Ca
2+
 binding within its individual 






This article is protected by copyright. All rights reserved. 
16 
 
cooperativity. It is generally accepted that a high level of positive cooperativity exists 
between EF1 and EF2 in the lower affinity N-lobe, and EF3 and EF4 in the higher affinity C-
lobe(Minowa & Yagi, 1984; Tsalkova & Privalov, 1985; Wang, 1985; Linse et al., 1991; 
Ikura, 1996; Sorensen & Shea, 1998; Masino et al., 2000; VanScyoc & Shea, 2001; Beccia et 
al., 2015). Our crystal structure of the N98S Ca
2+
/CaM:IQ domain is distinctive because it 
shows uncoupled Ca
2+
-binding cooperativity in the C-lobe, where a Ca
2+
 ion occupies EF4 
but is absent in EF3 (Fig. 7). This is observed for one complex in the AU, whereas the other 
complex retains Ca
2+
 ions at all four sites (Fig. 6). This suggests that there would be an effect 
on the Hill coefficient, but we were unable to test this via intrinsic CaM fluorescence, 
because the IQ peptide interferes with the Tyr fluorescence of CaM.  
The situation is different for the D96V and N98I mutations, where Ca
2+
 binding to EF3 seems 
permanently disrupted(Wang et al., 2018). The current structure also highlights the 
importance of free Ca
2+
 concentration, as a previous structure of the N98S variant at high 
Ca
2+
 concentration exhibited only the fully Ca
2+
-saturated CaM conformation(Wang et al., 
2018). Our structure gives new insights into the disease mechanism of N98S. In the 4 Ca
2+
-
bound state, N98S CaM exhibits strain in the main chain of EF3. In the 3 Ca
2+
-bound state, 
N98S CaM undergoes large conformational changes in the C-lobe that alter interactions with 
the CaV1.2 IQ domain in a manner similar to the previously characterized D96V and N98I 
mutants(Wang et al., 2018), consistent with the observation that N98S CaM is able to mildly 
suppress CaV1.2 CDI(Limpitikul et al., 2014). N98S CaM has also been shown to dysregulate 
RyR2(Nyegaard et al., 2012; Sondergaard et al., 2015a; Sondergaard et al., 2015b). In 
addition, a cryo-EM structure of the KCNQ1 channel in complex with Ca
2+
/CaM showed a 
direct interaction between Asn98 and the voltage-sensing domain(Sun & MacKinnon, 2017), 
and introducing the N98S mutation resulted in a right shift of the conductance-voltage (G-V) 
relationship. Depending on which interactions with various protein targets are affected, 
several pathological outcomes are possible. This may explain why the N98S variant results in 
a broad range of disease phenotypes, including CPVT, LQTS, IVF, and SUD phenotypes in 
different individuals(Nyegaard et al., 2012; Makita et al., 2014; Crotti et al., 2019). 
The majority (80%) of CaM variants are located in the C-lobe, with 89% of these affecting 
Ca
2+
-binding residues. To date, only two human disease mutations have been identified in the 
N-lobe of CaM, one of which is the CPVT-associated N54I variant in helix C(Nyegaard et 
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2014; Yin et al., 2014). Indeed, we found N54I CaM to have little effect on interactions with 
the CaV1.2 IQ domain, both in terms of binding affinities (Fig. 1A) and structure (Fig. 11). 
Even by itself, N54I CaM displays similar secondary structural elements to WT 
CaM(Sondergaard et al., 2015a). The mutation does not alter the C-lobe Ca
2+
 affinity, and 
only minutely impacts the N-lobe Ca
2+
 affinity(Nyegaard et al., 2012; Sondergaard et al., 
2015a; Sondergaard et al., 2015b). However, since the N-lobe has also been shown to 
associate with a CaM binding region, previously termed NSCaTE, near the N-terminus of the 
channel(Dick et al., 2008; Liu & Vogel, 2012), one possibility remains that the mutation 
affects this interaction. Due to the linkage of N54I CaM to CPVT(Nyegaard et al., 2012), it is 
likely that the major molecular pathological mechanism involves RyR2. N54I CaM did not 
show compromised interactions with a peptide of the RyR2 calmodulin binding domain 
(CaMBD2) at low or high Ca
2+
 concentrations(Nyegaard et al., 2012), so this variant is able 
to compete with WT CaM for binding to RyR2. N54I CaM displayed increased RyR2 open 
probability, RyR2-mediated Ca
2+
 release, and susceptibility for SOICR(Hwang et al., 2014; 
Sondergaard et al., 2015b). Zebrafish embryos injected with N54I CaM mRNA displayed 
increased heart rate under β-adrenergic stimulation, analogous to adrenergic induced 
tachycardia in humans(Sondergaard et al., 2015a). Given the lack of structural and functional 
effects of N54I CaM on CaV1.2, aberrant regulation of RyR2 is the more probable cause of 
CPVT. Of note, a recent report also found an effect of the N54I mutation on the Ca
2+
-
activated potassium channel SK3, showing an additional ion channel to play a role in the 
pathophysiology of CaM arrhythmia mutations(Saljic et al., 2019).  
Thus far, all structural studies of CaM disease mutations have been performed in the context 
of the CaV1.2 IQ domain. However, with available cryo-EM structures of CaM bound to full-
length RyR2(Gong et al., 2019) or KCNQ1 potassium channels(Sun & MacKinnon, 2017), as 
well as NMR and crystal structures of NaV1.5 cytosolic fragments bound to apoCaM(Chagot 
& Chazin, 2011; Wang et al., 2012; Gabelli et al., 2014; Wang et al., 2014) or 
Ca
2+
/CaM(Sarhan et al., 2012; Johnson et al., 2018; Gardill et al., 2019), a structural 
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Data collection     
Space group P21212 P212121 P21221 P21 
Cell dimensions     






59.4, 43.4, 67.0 






90.0, 111.9, 90.0 








Rmerge (%) 3.1 (48.6) 4.5 (51.8) 12.1 (100.1) 3.9 (25.5) 
Rmeas (%) 3.8 (58.8) 5.4 (63.0) 12.8 (105.3) 5.3 (34.9) 
I/(I) 17.06 (2.11) 13.50 (2.06) 16.32 (2.22) 11.55 (2.51) 
CC1/2
 
99.9 (79.9) 99.9 (81.3) 99.9 (74.2) 99.7 (88.3) 
Completeness (%) 97.5 (97.6) 98.6 (98.4) 99.9 (99.9) 89.6 (69.0) 
Redundancy 2.93 (2.98) 2.93 (2.94) 10.61 (10.39) 1.72 (1.44) 
     
Refinement     
Resolution (Å) 49.04-2.40 35.66-1.65 35.58-1.70 35.56-1.75 
No. reflections 140090 85568 18437 56089 
Rwork / Rfree 23.18/28.27 17.80/20.88 17.12/20.04 16.36/20.09 
No. atoms     
    Protein 11328 2734 1450 2766 
    Ligand 29 9 5 8 
    Water 20 301 159 217 
B factors     
    Protein 85.5 32.0 17.8 28.8 
    Ligand 82.3 24.6 14.4 22.3 
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R.m.s. deviations     
    Bond lengths (Å) 0.002 0.006 0.006 0.006 
    Bond angles () 0.371 0.745 0.760 0.735 
One crystal was used for each structure solution. Highest resolution shell is shown in 
parentheses. 
Figure 1 Binding and structural analysis of arrhythmogenic CaM mutants. (A) Binding 
affinity (KD,app) of full-length CaM variants for the CaV1.2 IQ domain at various free Ca
2+
 
concentrations by TAMRA fluorescence anisotropy. Error bars represent the standard 
deviation of three replicates. (B) Circular dichroism (CD) spectra of two Ca
2+
-free CaM 
variants. Smooth lines represent the mean and error bars represent the standard deviation of 
four replicates. CD spectra of Ca
2+
-saturated CaM variants, showing the overall spectrum (C) 
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Figure 2 Comparisons of WT and D130G CaM structures, obtained under saturating Ca
2+
 
concentrations (10 mM CaCl2). Stick representations of EF4 of (A) WT Ca
2+
/CaM (PDB ID 
code 3G43), (B) D130G Ca
2+
/CaM (chain K), (C) D130G Ca
2+
/CaM (chain M), and (D) WT 
apoCaM (PDB ID code 1QX5). The conformation of EF4 is thus different from both WT 
apoCaM and Ca
2+
/CaM. Residue 130 is shown in black and the Ca
2+
 ion as a sphere. Selected 
residues are labelled. (E) Superposition of the C-lobes of WT Ca
2+
/CaM (white) and D130G 
Ca
2+
/CaM (blue) based on helix E. C-lobes are shown in ribbon representation; helices are 
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Figure 3 The D130G Ca
2+
/CaM:IQ domain complex forms a dimer in the crystal structure 
but not in solution. (A) Dimeric D130G Ca
2+
/CaMs (cartoon: blue, purple) bound to IQ 
domains (sticks: orange, beige) as seen in the crystal structure. Ca
2+
 ions are shown as 
spheres; helices are labelled. (B) Zoom of residues at the dimer interface; selected residues 
are shown in sticks and labelled. (C) Chromatogram of the WT and D130G Ca
2+
/CaM:IQ 
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Figure 4 Comparisons of WT and D130G Ca
2+
/CaM interactions with the IQ domain. 
Interactions of (A) WT (PDB ID code 3G43) and (B) D130G Ca
2+
/CaM with the IQ domain. 
The IQ domain is shown in stick representation; CaM is shown in surface representation with 
the colors indicating electrostatic potential (red: negative; blue: positive). Zoom of (C) WT 
and (D) D130G C-lobe interactions with the IQ domain. Selected residues are shown in sticks 
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Figure 5 Comparisons of WT and Q136P Ca
2+
/CaM:IQ domain structures, obtained under 
saturating Ca
2+
 concentrations (10 mM CaCl2). (A) Superpositions of EF4 of WT (PDB ID 
code 2BE6, white) and Q136P Ca
2+
/CaM (blue). EF4 is shown in stick representation, P136 
in black, and Ca
2+
 ions as spheres. (B) Zoomed and rotated view around the Q136P mutation 
site. (C) Superpositions of the WT and Q136P C-lobes, shown around residue Y99. 
Interactions of C-lobes of (D) WT and (E) Q136P with the IQ domain. The IQ domain is 
shown in stick representation; C-lobes are shown in surface representation with the colors 
indicating electrostatic potential (red: negative; blue: positive); selective residues are shown 
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Figure 6 Comparisons of WT and N98S (chain B) Ca
2+
/CaM:IQ structures. The N98S 
structure was solved at a free Ca
2+
 concentration of ~10 μM. Stick representations of EF3 of 
(A) WT (PDB ID code 2BE6) and (B) N98S (chain B) Ca
2+
/CaM. Residue 98 is shown in 
black and Ca
2+
 ions as spheres. (C) Overall superposition of the C-lobes of WT (white) and 
N98S (chain B, blue) Ca
2+
/CaM. C-lobes are shown in ribbon representation; helices are 
labelled. (D) Superposition of WT (white) and N98S (chain B, N-lobe in green, C-lobe in 
blue) Ca
2+
/CaM:IQ based on the IQ domain (the IQ domain bound to the N98S mutant is 
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Figure 7 Comparisons of WT, N98I, and N98S (chain A) Ca
2+
/CaM:IQ structures. N98I was 
previously solved under saturating Ca
2+
 levels (10 mM CaCl2) (Wang et al., 2018), whereas 
N98S here crystallized at 10 μM free Ca
2+
. Stick representations of EF3 of (A) N98I (PDB ID 
code 6DAD) and (B) N98S (chain A) Ca
2+
/CaM. Residue 98 is shown in black, Na
+
 ion as a 
purple sphere, and water molecules as red spheres. (C) Superposition of C-lobes of WT (PDB 
ID code 2BE6, white) and N98S (chain A, blue) Ca
2+
/CaM based on helix E. C-lobes are 
shown in ribbon representation, residue 98 in black, Na
+
 ion as a purple sphere, and Ca
2+ 
ions 
as white/blue spheres; helices are labelled. (D) Superposition of WT (white) and N98S (chain 
A, N-lobe in green, C-lobe in blue) Ca
2+
/CaM:IQ based on the IQ domain (IQ of N98S 
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Figure 8 Comparisons of WT, N98I, and N98S (chain A) Ca
2+
/CaM:IQ structures. N98I was 
previously solved under saturating Ca
2+
 levels (10 mM CaCl2) (Wang et al., 2018), whereas 
N98S here crystallized at 10 μM free Ca
2+
. (A) Superpositions of EF3 of WT (PDB ID code 
2BE6, white), N98I (PDB ID code 6DAD, gray), and N98S (chain A, blue) Ca
2+
/CaM. EF3 is 
shown in stick representation, residue 98 in black, Na
+
 ion as a purple sphere, and Ca
2+
 ions 
as gray/blue spheres. (B) Overall superposition of the C-lobes of N98I (gray) and N98S 
(chain A, blue) Ca
2+
/CaM. C-lobes are shown in ribbon representation; helices are labelled. 
(C) Superpositions of N98I (gray) and N98S (chain A, N-lobe in green, C-lobe in blue) 
Ca
2+
/CaM based on the IQ domain (IQ of N98S mutant is orange). CaM is shown in cartoon 
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N]-HSQC spectra of the Ca
2+
-loaded form of CaM bound to the 
CaV1.2 IQ peptide. All experiments were performed under saturating Ca
2+
 concentrations (1 
mM CaCl2). Chemical shifts for WT CaM are shown in black, N98S CaM in red. The left 
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N]-HSQC spectra of Ca
2+
-saturated CaM variants bound to the 
CaV1.2 IQ domain (all at 1 mM CaCl2): WT CaM is shown in black, D96V in blue, and N98S 
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Figure 11 Comparisons of WT and N54I Ca
2+
/CaM:IQ structures, obtained under saturating 
Ca
2+
 concentrations (10 mM CaCl2). (A) Superposition of WT (PDB ID code 3G43, white) 
and N54I (N-lobe in green, C-lobe in blue) Ca
2+
/CaM based on the IQ domain (IQ of N54I 
mutant is orange). CaM is shown in cartoon representation, IQ domain as sticks, and Ca
2+
 
ions as spheres. (B) Overall superposition of the N-lobes of WT (white) and N54I (green) 
Ca
2+
/CaM. N-lobes are shown in ribbon representation and I54 in black; helices are labelled. 
(C) Superposition of helix C of the WT and N54I N-lobes, shown in stick representation.  
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